Drug intelligence / Profile preview

cudrania tricuspidata extract

Development stage
Unknown
Lead developer
Hy Co
Modality
Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
Administration
Oral
01

Overview

Cudrania tricuspidata extract (CTE) is a botanical extract derived from the leaves, roots, or bark of Cudrania tricuspidata (also known as Maclura tricuspidata or Chinese mulberry). Developed primarily by hy (formerly Korea Yakult), the extract is used as a traditional folk remedy and has been clinically evaluated for the treatment of functional dyspepsia. CTE acts as a gastroprotective agent by reducing gastric acid secretion through the competitive inhibition of histamine H2 receptors (H2R) and by increasing the expression of gastric mucin genes (such as MUC5AC and MUC6) to protect the gastric mucosa. Preclinical studies have also demonstrated its potential anti-inflammatory, anti-obesity, and antidiabetic properties, including the inhibition of protein tyrosine phosphatase 1B (PTP1B) and reduction of oxidative stress.

Other names
Cudrania tricuspidata leaf extractCudrania tricuspidata root extractMaclura tricuspidata extractcudrania tricuspidata ethanol extractcudrania tricuspidata hydrophilic extract
02

Targets

HRH2 (Histamine H2 Receptor)

Beyond the preview

Go deeper on cudrania tricuspidata extract.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on cudrania tricuspidata extract.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call